Participants were evaluated subjectively and objectively on the first, fourth, eighth, and 12th visits
While 503(B) pharmacies provide medications for clinicians to dispense, 503(A) pharmacies create drugs tailored for individual prescriptions
Drugs like retatrutide, CagriSema, survodutide, and orforglipron promise to address the limitations of current therapies and may unlock new levels of weight loss, health protection, and accessibility
However, GLP-1 medications already address the primary metabolic problems keto targets (insulin resistance, appetite control), making extreme carbohydrate restriction unnecessary for most patients
Semaglutide (a glucagon-like peptide-1 or GLP-1 receptor agonist) should generally appear clear and colorless
Each plan type has different rules for coverage and out-of-pocket costs